| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Aortic Aneurysm, Abdominal | 24 | 2022 | 443 | 4.110 |
Why?
|
| Carotid Stenosis | 13 | 2023 | 133 | 2.140 |
Why?
|
| Arteriosclerosis | 23 | 2002 | 138 | 2.100 |
Why?
|
| Imaging, Three-Dimensional | 7 | 2020 | 359 | 1.800 |
Why?
|
| Endovascular Procedures | 9 | 2019 | 724 | 1.660 |
Why?
|
| Ultrasonography, Doppler, Duplex | 4 | 2023 | 50 | 1.630 |
Why?
|
| Elective Surgical Procedures | 7 | 2015 | 158 | 1.620 |
Why?
|
| Blood Vessel Prosthesis Implantation | 11 | 2016 | 792 | 1.590 |
Why?
|
| Blood Vessel Prosthesis | 31 | 2015 | 530 | 1.560 |
Why?
|
| Vascular Surgical Procedures | 9 | 2015 | 565 | 1.440 |
Why?
|
| Endarterectomy, Carotid | 9 | 2012 | 92 | 1.370 |
Why?
|
| Contrast Media | 10 | 2020 | 469 | 1.360 |
Why?
|
| Decision Support Techniques | 4 | 2018 | 280 | 1.290 |
Why?
|
| Carotid Artery, Internal | 6 | 2023 | 67 | 1.190 |
Why?
|
| Aortic Rupture | 5 | 2022 | 118 | 1.190 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 8 | 2018 | 109 | 1.160 |
Why?
|
| Venous Insufficiency | 3 | 2016 | 12 | 1.140 |
Why?
|
| Aged | 86 | 2020 | 19067 | 1.060 |
Why?
|
| Femoral Artery | 24 | 2011 | 190 | 1.030 |
Why?
|
| Endoleak | 3 | 2016 | 43 | 1.020 |
Why?
|
| Ultrasonography | 10 | 2022 | 941 | 1.010 |
Why?
|
| von Willebrand Factor | 11 | 2011 | 197 | 0.970 |
Why?
|
| Foramen Ovale, Patent | 3 | 2009 | 15 | 0.960 |
Why?
|
| Leg | 6 | 2020 | 154 | 0.930 |
Why?
|
| Tomography, X-Ray Computed | 13 | 2022 | 2043 | 0.900 |
Why?
|
| Arteries | 9 | 2020 | 222 | 0.880 |
Why?
|
| Middle Aged | 82 | 2020 | 25966 | 0.880 |
Why?
|
| Aged, 80 and over | 35 | 2020 | 6373 | 0.860 |
Why?
|
| Aortic Aneurysm | 9 | 2016 | 224 | 0.820 |
Why?
|
| Stents | 9 | 2015 | 867 | 0.820 |
Why?
|
| Hospital Mortality | 8 | 2018 | 1009 | 0.800 |
Why?
|
| Thrombosis | 11 | 2022 | 519 | 0.790 |
Why?
|
| Endothelium, Vascular | 8 | 2002 | 515 | 0.780 |
Why?
|
| Magnetic Resonance Angiography | 4 | 2020 | 169 | 0.770 |
Why?
|
| Prospective Studies | 26 | 2023 | 6028 | 0.770 |
Why?
|
| Intracranial Embolism | 5 | 2011 | 25 | 0.760 |
Why?
|
| Postoperative Complications | 26 | 2019 | 3011 | 0.750 |
Why?
|
| State Medicine | 2 | 2015 | 12 | 0.710 |
Why?
|
| England | 8 | 2016 | 57 | 0.710 |
Why?
|
| Foot | 1 | 2020 | 63 | 0.700 |
Why?
|
| Male | 96 | 2020 | 60040 | 0.660 |
Why?
|
| Aortography | 11 | 2022 | 200 | 0.650 |
Why?
|
| Treatment Outcome | 29 | 2023 | 12116 | 0.650 |
Why?
|
| Popliteal Artery | 10 | 2004 | 53 | 0.630 |
Why?
|
| Carotid Artery Diseases | 10 | 2002 | 147 | 0.620 |
Why?
|
| Female | 89 | 2020 | 65444 | 0.610 |
Why?
|
| Humans | 135 | 2023 | 123170 | 0.610 |
Why?
|
| Dementia, Vascular | 1 | 2018 | 16 | 0.610 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2016 | 222 | 0.600 |
Why?
|
| Reproducibility of Results | 11 | 2018 | 2848 | 0.560 |
Why?
|
| Peripheral Arterial Disease | 1 | 2020 | 269 | 0.550 |
Why?
|
| Ultrasonography, Doppler | 2 | 2016 | 197 | 0.550 |
Why?
|
| Iliac Vein | 1 | 2016 | 34 | 0.540 |
Why?
|
| Exercise Test | 2 | 2014 | 250 | 0.530 |
Why?
|
| Polyethylene Terephthalates | 16 | 2004 | 40 | 0.530 |
Why?
|
| Pelvis | 1 | 2016 | 68 | 0.530 |
Why?
|
| Risk Factors | 25 | 2022 | 10010 | 0.530 |
Why?
|
| Preoperative Care | 4 | 2014 | 350 | 0.520 |
Why?
|
| Ultrasonography, Doppler, Color | 2 | 2014 | 57 | 0.510 |
Why?
|
| Cardiac Surgical Procedures | 4 | 2018 | 1099 | 0.500 |
Why?
|
| Saphenous Vein | 7 | 2009 | 53 | 0.490 |
Why?
|
| Predictive Value of Tests | 12 | 2018 | 2112 | 0.490 |
Why?
|
| Stockings, Compression | 1 | 2014 | 3 | 0.480 |
Why?
|
| Hemodilution | 2 | 2006 | 15 | 0.480 |
Why?
|
| Blood Flow Velocity | 7 | 2023 | 448 | 0.470 |
Why?
|
| Ankle Injuries | 1 | 2014 | 33 | 0.460 |
Why?
|
| Practice Guidelines as Topic | 3 | 2018 | 1259 | 0.460 |
Why?
|
| Aorta, Abdominal | 10 | 2022 | 120 | 0.450 |
Why?
|
| Follow-Up Studies | 24 | 2014 | 5046 | 0.440 |
Why?
|
| Ovary | 1 | 2016 | 389 | 0.440 |
Why?
|
| Global Health | 1 | 2018 | 557 | 0.440 |
Why?
|
| Critical Care | 2 | 2018 | 645 | 0.440 |
Why?
|
| Adult | 43 | 2018 | 29034 | 0.430 |
Why?
|
| Severity of Illness Index | 7 | 2012 | 2836 | 0.420 |
Why?
|
| Intercellular Adhesion Molecule-1 | 5 | 2001 | 133 | 0.420 |
Why?
|
| Fractures, Bone | 1 | 2014 | 185 | 0.400 |
Why?
|
| Angiography | 8 | 2019 | 215 | 0.390 |
Why?
|
| Blood Platelets | 8 | 2001 | 333 | 0.380 |
Why?
|
| P-Selectin | 4 | 2001 | 77 | 0.380 |
Why?
|
| Thrombomodulin | 4 | 2000 | 24 | 0.380 |
Why?
|
| Polytetrafluoroethylene | 8 | 2004 | 80 | 0.380 |
Why?
|
| Acute Kidney Injury | 1 | 2018 | 608 | 0.370 |
Why?
|
| Cerebrovascular Circulation | 3 | 2006 | 424 | 0.370 |
Why?
|
| Risk Assessment | 10 | 2014 | 3329 | 0.370 |
Why?
|
| Parkinson Disease | 1 | 2018 | 669 | 0.370 |
Why?
|
| Angioplasty, Balloon | 3 | 2011 | 161 | 0.370 |
Why?
|
| Aortic Aneurysm, Thoracic | 2 | 2015 | 660 | 0.360 |
Why?
|
| Varicose Veins | 2 | 2011 | 28 | 0.350 |
Why?
|
| Arterial Occlusive Diseases | 8 | 2004 | 127 | 0.350 |
Why?
|
| Cardiopulmonary Bypass | 3 | 2001 | 342 | 0.330 |
Why?
|
| Embolism, Paradoxical | 1 | 2009 | 4 | 0.330 |
Why?
|
| E-Selectin | 3 | 2000 | 42 | 0.330 |
Why?
|
| United Kingdom | 6 | 2013 | 191 | 0.330 |
Why?
|
| Cell Adhesion Molecules | 2 | 2002 | 225 | 0.330 |
Why?
|
| Aorta | 4 | 2019 | 541 | 0.330 |
Why?
|
| Models, Statistical | 1 | 2012 | 474 | 0.330 |
Why?
|
| Renal Insufficiency | 1 | 2011 | 233 | 0.320 |
Why?
|
| Inflammation Mediators | 3 | 2001 | 233 | 0.320 |
Why?
|
| Peripheral Vascular Diseases | 5 | 2004 | 89 | 0.320 |
Why?
|
| Carotid Arteries | 8 | 2019 | 151 | 0.320 |
Why?
|
| Dipyridamole | 8 | 1991 | 29 | 0.310 |
Why?
|
| Mass Screening | 4 | 2012 | 790 | 0.310 |
Why?
|
| Aneurysm | 9 | 1985 | 88 | 0.310 |
Why?
|
| General Surgery | 3 | 2003 | 203 | 0.300 |
Why?
|
| Stroke | 4 | 2012 | 958 | 0.300 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2009 | 240 | 0.300 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 3526 | 0.290 |
Why?
|
| Fibrinogen | 6 | 1998 | 150 | 0.290 |
Why?
|
| Platelet Aggregation | 8 | 2011 | 120 | 0.280 |
Why?
|
| ROC Curve | 3 | 2014 | 557 | 0.280 |
Why?
|
| Solubility | 7 | 2002 | 131 | 0.280 |
Why?
|
| Vascular Patency | 9 | 2015 | 203 | 0.280 |
Why?
|
| Iliac Artery | 7 | 2008 | 92 | 0.280 |
Why?
|
| Observer Variation | 3 | 2016 | 302 | 0.280 |
Why?
|
| Health Services Accessibility | 1 | 2012 | 594 | 0.270 |
Why?
|
| Aspirin | 8 | 1991 | 224 | 0.270 |
Why?
|
| Blood Transfusion | 3 | 2006 | 302 | 0.270 |
Why?
|
| Myocardial Infarction | 7 | 1998 | 998 | 0.270 |
Why?
|
| Blood Volume | 1 | 2006 | 80 | 0.260 |
Why?
|
| Blood Loss, Surgical | 1 | 2006 | 146 | 0.250 |
Why?
|
| Ischemia | 4 | 2001 | 337 | 0.250 |
Why?
|
| Intraoperative Care | 2 | 2003 | 103 | 0.250 |
Why?
|
| Constriction, Pathologic | 3 | 2023 | 238 | 0.240 |
Why?
|
| Coated Materials, Biocompatible | 2 | 2004 | 42 | 0.240 |
Why?
|
| Indium | 6 | 1985 | 8 | 0.240 |
Why?
|
| Oxygen | 3 | 2003 | 539 | 0.240 |
Why?
|
| Skin Transplantation | 2 | 2020 | 60 | 0.240 |
Why?
|
| Middle Cerebral Artery | 3 | 2018 | 110 | 0.240 |
Why?
|
| Blood Pressure | 5 | 2005 | 1315 | 0.240 |
Why?
|
| Varicose Ulcer | 3 | 2020 | 5 | 0.230 |
Why?
|
| Sensitivity and Specificity | 4 | 2023 | 2024 | 0.230 |
Why?
|
| Pilot Projects | 4 | 2020 | 1387 | 0.230 |
Why?
|
| Time Factors | 13 | 2018 | 6204 | 0.230 |
Why?
|
| Coronary Artery Bypass | 5 | 2001 | 485 | 0.220 |
Why?
|
| Valsalva Maneuver | 2 | 2016 | 10 | 0.220 |
Why?
|
| Intraoperative Complications | 2 | 2001 | 175 | 0.220 |
Why?
|
| Heparin | 2 | 2004 | 227 | 0.220 |
Why?
|
| Financing, Government | 1 | 2003 | 30 | 0.220 |
Why?
|
| Biomarkers | 7 | 2002 | 2942 | 0.220 |
Why?
|
| Carotid Sinus | 1 | 2002 | 6 | 0.210 |
Why?
|
| Angiography, Digital Subtraction | 2 | 2020 | 51 | 0.210 |
Why?
|
| Aneurysm, False | 1 | 2004 | 101 | 0.210 |
Why?
|
| Lidocaine | 1 | 2002 | 48 | 0.210 |
Why?
|
| Chi-Square Distribution | 3 | 2014 | 586 | 0.210 |
Why?
|
| Anesthesia, Local | 1 | 2002 | 48 | 0.200 |
Why?
|
| Regional Blood Flow | 2 | 2015 | 211 | 0.200 |
Why?
|
| Cost-Benefit Analysis | 4 | 2015 | 501 | 0.200 |
Why?
|
| Vascular Diseases | 4 | 1998 | 163 | 0.200 |
Why?
|
| Anesthetics, Local | 1 | 2002 | 80 | 0.200 |
Why?
|
| Erythrocyte Transfusion | 1 | 2003 | 121 | 0.190 |
Why?
|
| Nerve Block | 1 | 2002 | 68 | 0.190 |
Why?
|
| Transplantation Immunology | 1 | 2001 | 53 | 0.190 |
Why?
|
| Renal Artery | 2 | 2019 | 74 | 0.190 |
Why?
|
| Single-Blind Method | 2 | 2014 | 235 | 0.190 |
Why?
|
| Graft Occlusion, Vascular | 8 | 2001 | 95 | 0.190 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 2 | 1998 | 63 | 0.190 |
Why?
|
| Carotid Artery, External | 2 | 2000 | 5 | 0.190 |
Why?
|
| Foreign-Body Migration | 2 | 2015 | 73 | 0.180 |
Why?
|
| Surgical Mesh | 2 | 1999 | 62 | 0.180 |
Why?
|
| Cerebrovascular Disorders | 4 | 1998 | 117 | 0.180 |
Why?
|
| Fingers | 1 | 2020 | 65 | 0.170 |
Why?
|
| Leukocytes | 1 | 2001 | 207 | 0.170 |
Why?
|
| Melanocytes | 1 | 2020 | 47 | 0.170 |
Why?
|
| Cell Transplantation | 1 | 2020 | 45 | 0.170 |
Why?
|
| Staphylococcus epidermidis | 1 | 2000 | 41 | 0.170 |
Why?
|
| Venous Thrombosis | 2 | 2014 | 180 | 0.170 |
Why?
|
| Survival Analysis | 4 | 2017 | 1469 | 0.170 |
Why?
|
| Keratinocytes | 1 | 2020 | 60 | 0.170 |
Why?
|
| Body Weights and Measures | 1 | 2019 | 41 | 0.170 |
Why?
|
| Mammary Arteries | 1 | 2019 | 26 | 0.170 |
Why?
|
| Hernia, Inguinal | 1 | 1999 | 41 | 0.160 |
Why?
|
| Scleroderma, Systemic | 1 | 2020 | 117 | 0.160 |
Why?
|
| Awards and Prizes | 1 | 2000 | 63 | 0.160 |
Why?
|
| Radioisotopes | 6 | 1985 | 38 | 0.160 |
Why?
|
| Young Adult | 6 | 2017 | 8865 | 0.160 |
Why?
|
| Memory Disorders | 1 | 2001 | 235 | 0.160 |
Why?
|
| Prosthesis Design | 3 | 2015 | 669 | 0.160 |
Why?
|
| Blood Viscosity | 1 | 1998 | 13 | 0.160 |
Why?
|
| Phantoms, Imaging | 1 | 2019 | 127 | 0.160 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 1999 | 66 | 0.160 |
Why?
|
| Smoking | 4 | 1998 | 1031 | 0.160 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 1998 | 63 | 0.160 |
Why?
|
| Cognition | 1 | 2003 | 735 | 0.160 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 1991 | 257 | 0.160 |
Why?
|
| Recovery of Function | 2 | 2014 | 437 | 0.150 |
Why?
|
| Brachial Artery | 3 | 2007 | 38 | 0.150 |
Why?
|
| Societies, Medical | 2 | 2000 | 679 | 0.150 |
Why?
|
| Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 1998 | 26 | 0.150 |
Why?
|
| Blood Proteins | 1 | 1998 | 116 | 0.150 |
Why?
|
| Endarterectomy | 5 | 1997 | 22 | 0.150 |
Why?
|
| Antigens | 1 | 1998 | 156 | 0.150 |
Why?
|
| Replantation | 1 | 1998 | 54 | 0.150 |
Why?
|
| Prosthesis-Related Infections | 1 | 2000 | 176 | 0.150 |
Why?
|
| Heparin Antagonists | 1 | 1997 | 5 | 0.140 |
Why?
|
| Biomedical Research | 1 | 2003 | 519 | 0.140 |
Why?
|
| Swine | 2 | 2019 | 1154 | 0.140 |
Why?
|
| Protamines | 1 | 1997 | 13 | 0.140 |
Why?
|
| Models, Animal | 1 | 2019 | 464 | 0.140 |
Why?
|
| Intensive Care Units | 2 | 2018 | 481 | 0.140 |
Why?
|
| Multivariate Analysis | 3 | 2012 | 1416 | 0.140 |
Why?
|
| Double-Blind Method | 8 | 2011 | 1588 | 0.140 |
Why?
|
| Patient Outcome Assessment | 1 | 2017 | 94 | 0.140 |
Why?
|
| Cognition Disorders | 1 | 2001 | 554 | 0.140 |
Why?
|
| Supine Position | 1 | 2016 | 24 | 0.140 |
Why?
|
| Age Factors | 2 | 2015 | 2799 | 0.140 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2015 | 1004 | 0.140 |
Why?
|
| Problem-Based Learning | 1 | 1997 | 68 | 0.140 |
Why?
|
| Aorta, Thoracic | 5 | 1995 | 517 | 0.140 |
Why?
|
| Bioprosthesis | 2 | 1991 | 111 | 0.140 |
Why?
|
| Hospitals, University | 1 | 2016 | 96 | 0.130 |
Why?
|
| Patient Positioning | 1 | 2016 | 54 | 0.130 |
Why?
|
| Prosthesis Failure | 3 | 2014 | 159 | 0.130 |
Why?
|
| Hypercholesterolemia | 1 | 1998 | 226 | 0.130 |
Why?
|
| Prognosis | 6 | 2012 | 4505 | 0.130 |
Why?
|
| Leg Ulcer | 1 | 1995 | 11 | 0.130 |
Why?
|
| Retreatment | 1 | 2015 | 88 | 0.130 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 1998 | 667 | 0.130 |
Why?
|
| White Matter | 1 | 2018 | 181 | 0.130 |
Why?
|
| Quality-Adjusted Life Years | 2 | 2015 | 105 | 0.130 |
Why?
|
| Fibroblasts | 1 | 2020 | 878 | 0.130 |
Why?
|
| Hyperlipidemias | 1 | 1997 | 174 | 0.130 |
Why?
|
| Computed Tomography Angiography | 1 | 2016 | 194 | 0.120 |
Why?
|
| Models, Econometric | 1 | 2015 | 9 | 0.120 |
Why?
|
| Aortic Diseases | 3 | 2011 | 196 | 0.120 |
Why?
|
| Bandages | 1 | 1995 | 56 | 0.120 |
Why?
|
| Life Expectancy | 1 | 2015 | 50 | 0.120 |
Why?
|
| Staphylococcal Infections | 1 | 2000 | 552 | 0.120 |
Why?
|
| Perioperative Period | 1 | 2015 | 49 | 0.120 |
Why?
|
| Sulfur Hexafluoride | 1 | 2014 | 4 | 0.120 |
Why?
|
| Discriminant Analysis | 1 | 2014 | 27 | 0.120 |
Why?
|
| Odds Ratio | 2 | 2012 | 1243 | 0.120 |
Why?
|
| Educational Measurement | 1 | 1997 | 324 | 0.120 |
Why?
|
| Range of Motion, Articular | 1 | 2014 | 73 | 0.110 |
Why?
|
| Myocardial Ischemia | 1 | 1997 | 332 | 0.110 |
Why?
|
| Medical Audit | 1 | 2014 | 99 | 0.110 |
Why?
|
| Hemorrhage | 1 | 1997 | 459 | 0.110 |
Why?
|
| Area Under Curve | 1 | 2014 | 312 | 0.110 |
Why?
|
| Angioplasty | 2 | 2008 | 85 | 0.110 |
Why?
|
| Oxyquinoline | 2 | 1983 | 5 | 0.110 |
Why?
|
| Sepsis | 1 | 2017 | 478 | 0.110 |
Why?
|
| Recurrence | 4 | 2000 | 1422 | 0.110 |
Why?
|
| Aneurysm, Ruptured | 1 | 1993 | 36 | 0.110 |
Why?
|
| Adolescent | 9 | 2017 | 19095 | 0.110 |
Why?
|
| Microbubbles | 2 | 2014 | 8 | 0.110 |
Why?
|
| Health Status | 1 | 2015 | 374 | 0.100 |
Why?
|
| Logistic Models | 2 | 2012 | 1796 | 0.100 |
Why?
|
| Organometallic Compounds | 2 | 1983 | 106 | 0.100 |
Why?
|
| Chronic Disease | 6 | 2005 | 1167 | 0.100 |
Why?
|
| Brain | 2 | 2003 | 2947 | 0.100 |
Why?
|
| Hypertension | 3 | 1998 | 1284 | 0.100 |
Why?
|
| Reference Values | 4 | 2004 | 696 | 0.100 |
Why?
|
| Activities of Daily Living | 1 | 2014 | 404 | 0.100 |
Why?
|
| Disease Progression | 5 | 2012 | 2023 | 0.100 |
Why?
|
| Transforming Growth Factor beta3 | 1 | 2011 | 4 | 0.090 |
Why?
|
| Transplantation, Autologous | 3 | 2020 | 295 | 0.090 |
Why?
|
| Groin | 1 | 2011 | 15 | 0.090 |
Why?
|
| Aptamers, Nucleotide | 1 | 2011 | 24 | 0.090 |
Why?
|
| Sex Factors | 1 | 2015 | 1255 | 0.090 |
Why?
|
| National Health Programs | 1 | 2011 | 21 | 0.090 |
Why?
|
| Proportional Hazards Models | 1 | 2014 | 1305 | 0.090 |
Why?
|
| Ischemic Attack, Transient | 2 | 1998 | 51 | 0.090 |
Why?
|
| Dermatologic Agents | 1 | 2011 | 30 | 0.090 |
Why?
|
| Receptors, Prostaglandin | 1 | 1990 | 22 | 0.090 |
Why?
|
| Quality of Life | 2 | 2014 | 1932 | 0.090 |
Why?
|
| Albumins | 2 | 2006 | 88 | 0.090 |
Why?
|
| Prevalence | 2 | 2009 | 2405 | 0.090 |
Why?
|
| Alzheimer Disease | 1 | 2018 | 766 | 0.090 |
Why?
|
| Biphenyl Compounds | 1 | 1990 | 56 | 0.090 |
Why?
|
| Monitoring, Intraoperative | 2 | 2001 | 128 | 0.090 |
Why?
|
| Length of Stay | 3 | 2017 | 1285 | 0.090 |
Why?
|
| Retrospective Studies | 7 | 2014 | 15998 | 0.090 |
Why?
|
| Sclerosing Solutions | 1 | 2009 | 13 | 0.090 |
Why?
|
| Creatinine | 1 | 2011 | 380 | 0.090 |
Why?
|
| Cicatrix | 1 | 2011 | 125 | 0.080 |
Why?
|
| Spectroscopy, Near-Infrared | 2 | 2003 | 133 | 0.080 |
Why?
|
| Sclerotherapy | 1 | 2009 | 40 | 0.080 |
Why?
|
| Brain Ischemia | 1 | 2012 | 251 | 0.080 |
Why?
|
| Guideline Adherence | 1 | 2012 | 375 | 0.080 |
Why?
|
| Pulmonary Circulation | 1 | 2009 | 121 | 0.080 |
Why?
|
| Coronary Circulation | 1 | 2009 | 209 | 0.080 |
Why?
|
| Probability | 3 | 2008 | 322 | 0.080 |
Why?
|
| Polyethylene Glycols | 1 | 2009 | 216 | 0.080 |
Why?
|
| Lipoproteins | 3 | 1998 | 177 | 0.080 |
Why?
|
| Internship and Residency | 2 | 2003 | 1158 | 0.080 |
Why?
|
| Radiography | 3 | 2001 | 818 | 0.070 |
Why?
|
| Embolism, Air | 1 | 2007 | 25 | 0.070 |
Why?
|
| History, 20th Century | 2 | 2000 | 384 | 0.070 |
Why?
|
| Radiography, Interventional | 1 | 2008 | 87 | 0.070 |
Why?
|
| Case-Control Studies | 3 | 2020 | 3251 | 0.070 |
Why?
|
| Carotid Artery, Common | 1 | 2007 | 73 | 0.070 |
Why?
|
| Hip | 1 | 2006 | 20 | 0.070 |
Why?
|
| Transplantation, Homologous | 3 | 2001 | 657 | 0.070 |
Why?
|
| Leukoaraiosis | 1 | 2006 | 4 | 0.070 |
Why?
|
| Iohexol | 2 | 2006 | 20 | 0.070 |
Why?
|
| Laser-Doppler Flowmetry | 1 | 2006 | 52 | 0.060 |
Why?
|
| Tourniquets | 1 | 2005 | 10 | 0.060 |
Why?
|
| Diagnostic Techniques, Cardiovascular | 1 | 2005 | 20 | 0.060 |
Why?
|
| Coronary Disease | 2 | 2001 | 638 | 0.060 |
Why?
|
| Orthopedic Procedures | 1 | 2006 | 68 | 0.060 |
Why?
|
| Fluorocarbons | 1 | 2006 | 58 | 0.060 |
Why?
|
| Postoperative Period | 2 | 2001 | 329 | 0.060 |
Why?
|
| Veins | 1 | 2005 | 106 | 0.060 |
Why?
|
| Cohort Studies | 2 | 2011 | 4704 | 0.060 |
Why?
|
| Mesenteric Artery, Superior | 1 | 2004 | 35 | 0.060 |
Why?
|
| Hydroxyquinolines | 1 | 1983 | 2 | 0.060 |
Why?
|
| Random Allocation | 3 | 1998 | 423 | 0.060 |
Why?
|
| Tomography, Spiral Computed | 1 | 2003 | 16 | 0.060 |
Why?
|
| Nerve Compression Syndromes | 1 | 1983 | 20 | 0.050 |
Why?
|
| Atherosclerosis | 1 | 2011 | 829 | 0.050 |
Why?
|
| Budgets | 1 | 2003 | 18 | 0.050 |
Why?
|
| Spinal Nerve Roots | 1 | 1983 | 25 | 0.050 |
Why?
|
| Neoplasms | 1 | 1998 | 2766 | 0.050 |
Why?
|
| Reaction Time | 1 | 2003 | 169 | 0.050 |
Why?
|
| Comorbidity | 2 | 1998 | 1497 | 0.050 |
Why?
|
| Ligation | 2 | 2000 | 132 | 0.050 |
Why?
|
| Combined Modality Therapy | 2 | 2000 | 1240 | 0.050 |
Why?
|
| Blood Transfusion, Autologous | 1 | 2002 | 34 | 0.050 |
Why?
|
| Methods | 5 | 1987 | 147 | 0.050 |
Why?
|
| Cardiac Catheterization | 1 | 1986 | 633 | 0.050 |
Why?
|
| Attention | 1 | 2003 | 194 | 0.050 |
Why?
|
| Spine | 1 | 2003 | 143 | 0.050 |
Why?
|
| Obesity | 1 | 1993 | 2227 | 0.050 |
Why?
|
| Incidence | 2 | 2017 | 3049 | 0.050 |
Why?
|
| Thromboxane B2 | 1 | 2001 | 20 | 0.050 |
Why?
|
| Career Choice | 1 | 2003 | 143 | 0.050 |
Why?
|
| Pancreatic Elastase | 1 | 2001 | 13 | 0.050 |
Why?
|
| Subclavian Artery | 2 | 1979 | 71 | 0.050 |
Why?
|
| Models, Cardiovascular | 1 | 1983 | 180 | 0.050 |
Why?
|
| United States | 3 | 2009 | 10629 | 0.050 |
Why?
|
| Suture Techniques | 2 | 1986 | 198 | 0.050 |
Why?
|
| Radionuclide Imaging | 4 | 1993 | 151 | 0.050 |
Why?
|
| Wound Healing | 2 | 2020 | 452 | 0.050 |
Why?
|
| Hemodynamics | 1 | 2005 | 848 | 0.050 |
Why?
|
| Mesenteric Vascular Occlusion | 2 | 1982 | 28 | 0.050 |
Why?
|
| Confidence Intervals | 1 | 2001 | 279 | 0.050 |
Why?
|
| Neurologic Examination | 1 | 2001 | 192 | 0.050 |
Why?
|
| Drug Therapy, Combination | 3 | 1991 | 1149 | 0.050 |
Why?
|
| Umbilical Veins | 3 | 1993 | 71 | 0.050 |
Why?
|
| Animals | 4 | 2019 | 33728 | 0.040 |
Why?
|
| Sulfinpyrazone | 1 | 1980 | 1 | 0.040 |
Why?
|
| Cross-Sectional Studies | 2 | 2020 | 3380 | 0.040 |
Why?
|
| Dilatation, Pathologic | 2 | 2012 | 93 | 0.040 |
Why?
|
| Salvage Therapy | 1 | 2002 | 193 | 0.040 |
Why?
|
| Hepatic Artery | 2 | 1980 | 51 | 0.040 |
Why?
|
| Cytomegalovirus | 3 | 1987 | 268 | 0.040 |
Why?
|
| Compression Bandages | 1 | 2020 | 1 | 0.040 |
Why?
|
| Memory | 1 | 2003 | 360 | 0.040 |
Why?
|
| Mast Cells | 2 | 1998 | 74 | 0.040 |
Why?
|
| Collateral Circulation | 1 | 2000 | 45 | 0.040 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2000 | 42 | 0.040 |
Why?
|
| Survival Rate | 1 | 2004 | 1993 | 0.040 |
Why?
|
| Proof of Concept Study | 1 | 2019 | 29 | 0.040 |
Why?
|
| Triiodobenzoic Acids | 1 | 2019 | 28 | 0.040 |
Why?
|
| Statistics as Topic | 2 | 2006 | 251 | 0.040 |
Why?
|
| Southwestern United States | 1 | 1998 | 45 | 0.040 |
Why?
|
| Ossification, Heterotopic | 1 | 1998 | 41 | 0.040 |
Why?
|
| Bone Remodeling | 1 | 1998 | 54 | 0.040 |
Why?
|
| Rupture, Spontaneous | 2 | 1993 | 47 | 0.040 |
Why?
|
| Students, Medical | 1 | 2003 | 361 | 0.040 |
Why?
|
| Tunica Intima | 1 | 1998 | 59 | 0.040 |
Why?
|
| Blood Gas Monitoring, Transcutaneous | 1 | 1997 | 5 | 0.040 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 1998 | 124 | 0.040 |
Why?
|
| Leukocyte Elastase | 1 | 1997 | 19 | 0.040 |
Why?
|
| Organ Dysfunction Scores | 1 | 2017 | 47 | 0.040 |
Why?
|
| Hyperplasia | 1 | 1998 | 210 | 0.040 |
Why?
|
| Reoperation | 1 | 2001 | 819 | 0.040 |
Why?
|
| Granulocytes | 1 | 1997 | 65 | 0.040 |
Why?
|
| Organ Specificity | 1 | 1998 | 423 | 0.040 |
Why?
|
| Hematoma | 1 | 1998 | 92 | 0.040 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 1979 | 170 | 0.040 |
Why?
|
| Postprandial Period | 1 | 1997 | 77 | 0.030 |
Why?
|
| Prostheses and Implants | 1 | 1998 | 151 | 0.030 |
Why?
|
| Calcinosis | 1 | 1998 | 167 | 0.030 |
Why?
|
| Smoking Cessation | 1 | 1998 | 196 | 0.030 |
Why?
|
| Anesthesia | 1 | 1999 | 211 | 0.030 |
Why?
|
| Myocardial Revascularization | 1 | 1977 | 96 | 0.030 |
Why?
|
| Pain, Postoperative | 1 | 1999 | 255 | 0.030 |
Why?
|
| Surveys and Questionnaires | 2 | 1997 | 3660 | 0.030 |
Why?
|
| Patient Satisfaction | 1 | 2020 | 477 | 0.030 |
Why?
|
| Triglycerides | 2 | 1997 | 562 | 0.030 |
Why?
|
| Extracellular Matrix | 1 | 1997 | 231 | 0.030 |
Why?
|
| Models, Economic | 1 | 1996 | 51 | 0.030 |
Why?
|
| Perception | 1 | 1997 | 221 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1997 | 815 | 0.030 |
Why?
|
| Community Health Centers | 1 | 1995 | 39 | 0.030 |
Why?
|
| Dietary Fats | 1 | 1997 | 296 | 0.030 |
Why?
|
| Heart Murmurs | 1 | 1995 | 15 | 0.030 |
Why?
|
| Surgical Procedures, Operative | 1 | 1977 | 182 | 0.030 |
Why?
|
| Aging | 1 | 1982 | 1172 | 0.030 |
Why?
|
| Microscopy, Electron, Scanning | 3 | 1993 | 153 | 0.030 |
Why?
|
| Renal Dialysis | 1 | 1981 | 842 | 0.030 |
Why?
|
| Muscle, Smooth, Vascular | 3 | 1998 | 239 | 0.030 |
Why?
|
| Lipids | 1 | 1998 | 514 | 0.030 |
Why?
|
| Education, Medical | 1 | 1998 | 285 | 0.030 |
Why?
|
| Lymphoma | 1 | 1998 | 322 | 0.030 |
Why?
|
| Accidents, Traffic | 1 | 1995 | 103 | 0.030 |
Why?
|
| Acute Disease | 2 | 1997 | 1090 | 0.030 |
Why?
|
| Wounds and Injuries | 1 | 1997 | 363 | 0.030 |
Why?
|
| Wounds, Nonpenetrating | 1 | 1995 | 205 | 0.030 |
Why?
|
| Computer Simulation | 1 | 1996 | 637 | 0.030 |
Why?
|
| Indium Radioisotopes | 2 | 1993 | 10 | 0.030 |
Why?
|
| Drug Combinations | 2 | 1983 | 271 | 0.030 |
Why?
|
| Omentum | 1 | 1992 | 47 | 0.030 |
Why?
|
| Platelet Count | 2 | 1983 | 133 | 0.030 |
Why?
|
| Cell Death | 1 | 1993 | 242 | 0.030 |
Why?
|
| Motor Activity | 1 | 1995 | 520 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 3 | 1998 | 262 | 0.020 |
Why?
|
| Collagen | 1 | 1993 | 313 | 0.020 |
Why?
|
| Colorectal Neoplasms | 1 | 1998 | 560 | 0.020 |
Why?
|
| Europe | 1 | 2012 | 375 | 0.020 |
Why?
|
| Emergencies | 1 | 1993 | 175 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2014 | 752 | 0.020 |
Why?
|
| Platelet Adhesiveness | 2 | 1983 | 40 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 2012 | 303 | 0.020 |
Why?
|
| Intention to Treat Analysis | 1 | 2011 | 56 | 0.020 |
Why?
|
| Surgicenters | 1 | 2011 | 4 | 0.020 |
Why?
|
| Injections, Intradermal | 1 | 2011 | 31 | 0.020 |
Why?
|
| Receptors, Thromboxane | 1 | 1990 | 5 | 0.020 |
Why?
|
| Body Composition | 1 | 1993 | 513 | 0.020 |
Why?
|
| Epidemiologic Methods | 1 | 2011 | 111 | 0.020 |
Why?
|
| Cells, Cultured | 3 | 1993 | 3048 | 0.020 |
Why?
|
| Inflammation | 1 | 1998 | 1402 | 0.020 |
Why?
|
| Vertebral Artery | 2 | 1980 | 24 | 0.020 |
Why?
|
| Clinical Trials as Topic | 2 | 1983 | 1089 | 0.020 |
Why?
|
| Cell Survival | 1 | 1990 | 803 | 0.020 |
Why?
|
| Biological Dressings | 1 | 1987 | 4 | 0.020 |
Why?
|
| Body Mass Index | 1 | 1993 | 1541 | 0.020 |
Why?
|
| Patient Compliance | 1 | 1991 | 467 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 1 | 1987 | 258 | 0.020 |
Why?
|
| Cholesterol, LDL | 1 | 1990 | 557 | 0.020 |
Why?
|
| Tracheal Stenosis | 1 | 1986 | 31 | 0.020 |
Why?
|
| Brain Infarction | 1 | 2006 | 30 | 0.020 |
Why?
|
| Femoral Vein | 2 | 1990 | 50 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 1998 | 2486 | 0.020 |
Why?
|
| DNA, Viral | 1 | 1987 | 477 | 0.020 |
Why?
|
| Functional Laterality | 1 | 2006 | 181 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2006 | 425 | 0.010 |
Why?
|
| Diagnosis, Differential | 2 | 1983 | 1873 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 2006 | 533 | 0.010 |
Why?
|
| Trachea | 1 | 1986 | 201 | 0.010 |
Why?
|
| Anastomosis, Surgical | 1 | 2004 | 169 | 0.010 |
Why?
|
| Income | 1 | 2003 | 133 | 0.010 |
Why?
|
| Graft Survival | 1 | 2004 | 524 | 0.010 |
Why?
|
| Textiles | 1 | 1982 | 10 | 0.010 |
Why?
|
| Isotope Labeling | 1 | 1982 | 102 | 0.010 |
Why?
|
| Brachiocephalic Trunk | 1 | 1982 | 35 | 0.010 |
Why?
|
| Blood Coagulation | 1 | 1982 | 119 | 0.010 |
Why?
|
| Dogs | 2 | 1993 | 763 | 0.010 |
Why?
|
| Antigens, Viral | 1 | 1983 | 436 | 0.010 |
Why?
|
| Risk | 1 | 1983 | 749 | 0.010 |
Why?
|
| Antibodies, Viral | 1 | 1987 | 1134 | 0.010 |
Why?
|
| Celiac Artery | 2 | 1980 | 28 | 0.010 |
Why?
|
| Mesenteric Arteries | 2 | 1980 | 56 | 0.010 |
Why?
|
| Blood Circulation | 1 | 1980 | 23 | 0.010 |
Why?
|
| Life Style | 1 | 2003 | 402 | 0.010 |
Why?
|
| Lumbosacral Region | 1 | 1980 | 33 | 0.010 |
Why?
|
| Abdomen | 1 | 1980 | 130 | 0.010 |
Why?
|
| Injections | 1 | 1980 | 152 | 0.010 |
Why?
|
| Arteriovenous Fistula | 1 | 1980 | 56 | 0.010 |
Why?
|
| Neurologic Manifestations | 1 | 1979 | 6 | 0.010 |
Why?
|
| Physician-Patient Relations | 1 | 2003 | 426 | 0.010 |
Why?
|
| Acid Phosphatase | 1 | 1998 | 11 | 0.010 |
Why?
|
| Bone Morphogenetic Protein 6 | 1 | 1998 | 10 | 0.010 |
Why?
|
| Anesthesia, General | 1 | 1980 | 111 | 0.010 |
Why?
|
| Multicenter Studies as Topic | 2 | 1990 | 264 | 0.010 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 1998 | 33 | 0.010 |
Why?
|
| Giant Cells | 1 | 1998 | 34 | 0.010 |
Why?
|
| Kinetics | 1 | 1981 | 1313 | 0.010 |
Why?
|
| Thoracic Injuries | 1 | 1979 | 91 | 0.010 |
Why?
|
| Organ Culture Techniques | 1 | 1998 | 155 | 0.010 |
Why?
|
| Elastin | 1 | 1998 | 32 | 0.010 |
Why?
|
| Chymases | 1 | 1997 | 6 | 0.010 |
Why?
|
| Fibronectins | 1 | 1997 | 104 | 0.010 |
Why?
|
| Tryptases | 1 | 1997 | 20 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 1997 | 382 | 0.010 |
Why?
|
| Pulmonary Edema | 1 | 1977 | 49 | 0.010 |
Why?
|
| Skin | 1 | 1980 | 505 | 0.010 |
Why?
|
| Thoracotomy | 1 | 1997 | 108 | 0.010 |
Why?
|
| Antigens, CD | 1 | 1998 | 420 | 0.010 |
Why?
|
| Serine Endopeptidases | 1 | 1997 | 175 | 0.010 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 1997 | 193 | 0.010 |
Why?
|
| Cholesterol | 2 | 1989 | 525 | 0.010 |
Why?
|
| Neutrophils | 1 | 1997 | 372 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 1996 | 229 | 0.010 |
Why?
|
| Hospital Costs | 1 | 1996 | 178 | 0.010 |
Why?
|
| Macrophages | 1 | 1998 | 603 | 0.010 |
Why?
|
| Kidney Failure, Chronic | 1 | 1981 | 866 | 0.010 |
Why?
|
| Surface Properties | 1 | 1993 | 76 | 0.010 |
Why?
|
| Collagenases | 1 | 1992 | 18 | 0.010 |
Why?
|
| Endothelium | 1 | 1993 | 71 | 0.010 |
Why?
|
| Popliteal Vein | 1 | 1990 | 9 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 1993 | 1683 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 1992 | 900 | 0.000 |
Why?
|
| Simplexvirus | 1 | 1987 | 99 | 0.000 |
Why?
|
| Herpes Simplex | 1 | 1987 | 57 | 0.000 |
Why?
|
| Cardiovascular Diseases | 1 | 1979 | 1861 | 0.000 |
Why?
|
| Tracheotomy | 1 | 1986 | 35 | 0.000 |
Why?
|
| Ankle | 1 | 1986 | 29 | 0.000 |
Why?
|
| Tibia | 1 | 1986 | 70 | 0.000 |
Why?
|
| Cerebral Infarction | 1 | 1985 | 43 | 0.000 |
Why?
|
| Cytomegalovirus Infections | 1 | 1987 | 217 | 0.000 |
Why?
|
| Wounds, Gunshot | 1 | 1986 | 137 | 0.000 |
Why?
|
| Heart Failure | 1 | 1977 | 2125 | 0.000 |
Why?
|
| Microscopy, Electron | 1 | 1983 | 391 | 0.000 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1983 | 462 | 0.000 |
Why?
|
| Intubation, Intratracheal | 1 | 1986 | 291 | 0.000 |
Why?
|
| Texas | 2 | 1982 | 3547 | 0.000 |
Why?
|
| Base Sequence | 1 | 1987 | 3093 | 0.000 |
Why?
|
| Splenic Artery | 1 | 1980 | 22 | 0.000 |
Why?
|
| Child | 2 | 1982 | 24225 | 0.000 |
Why?
|